Fig. 2.

Clinical symptoms and disease course of typical CIDP versus CIDP variants. A, B Clinical symptoms and MRC scores on initial admission are depicted. Symptoms are displayed as relative percentage of all patients. C, D INCAT scores were determined at initial diagnosis (0), after 12, 24 and 36 months. Mean scores ± SEM are shown. Data was available from (typical CIDP/CIDP variants) 180/43 (diagnosis), 151/35 (after 12 months), 121/29 (after 24 months) and 110/27 (after 36 months) patients. A p-value ≥ 0.05 was classified as not significant, p < 0.05 (*) as significant, p < 0.01 (**), p < 0.001 (***), and p < 0.0001 (****) as highly significant. CIDP chronic inflammatory demyelinating polyneuropathy, INCAT inflammatory neuropathy cause and treatment, MRC Medical Research Council, SEM standard error of the mean